[{"address1": "27 West 24th Street", "address2": "Suite 702", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "646 481 9832", "website": "https://www.tourmalinebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sandeep C. Kulkarni M.D.", "age": 42, "title": "Co-Founder, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 848250, "exercisedValue": 0, "unexercisedValue": 3257194}, {"maxAge": 1, "name": "Mr. W. Bradford Middlekauff J.D.", "age": 62, "title": "Chief Business Officer, General Counsel & Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 582250, "exercisedValue": 0, "unexercisedValue": 727921}, {"maxAge": 1, "name": "Ms. Dora  Rau", "title": "Senior VP & Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Hagn Pharm.D.", "title": "Senior VP and Head of Commercial & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil M. deGoma M.D.", "title": "Senior Vice President of Medical Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristine  Erickson O.D., Ph.D.", "title": "VP & TA Head of Ophthalmology, Medical Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John  Walsh M.D.", "title": "VP & Head of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Famina  Hemani Pharm.D.", "title": "VP & Head of Pharmacovigilance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Don  Fitch", "title": "Senior Vice President of Product Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 47.6, "open": 47.6, "dayLow": 47.59, "dayHigh": 47.695, "regularMarketPreviousClose": 47.6, "regularMarketOpen": 47.6, "regularMarketDayLow": 47.59, "regularMarketDayHigh": 47.695, "payoutRatio": 0.0, "forwardPE": -13.07967, "volume": 988444, "regularMarketVolume": 988444, "averageVolume": 655598, "averageVolume10days": 3092720, "averageDailyVolume10Day": 3092720, "bid": 47.6, "ask": 47.61, "bidSize": 4, "askSize": 1, "marketCap": 1223210368, "fiftyTwoWeekLow": 11.56, "fiftyTwoWeekHigh": 47.7, "fiftyDayAverage": 23.3956, "twoHundredDayAverage": 18.827375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 984119872, "profitMargins": 0.0, "floatShares": 13101258, "sharesOutstanding": 25692300, "sharesShort": 2654210, "sharesShortPriorMonth": 2631172, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.1033, "heldPercentInsiders": 0.22061001, "heldPercentInstitutions": 0.89917, "shortRatio": 14.74, "shortPercentOfFloat": 0.115600005, "impliedSharesOutstanding": 25692300, "bookValue": 10.088, "priceToBook": 4.7194686, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -88474000, "trailingEps": -3.44, "forwardEps": -3.64, "lastSplitFactor": "1:10", "lastSplitDate": 1697760000, "enterpriseToEbitda": -9.61, "52WeekChange": 1.3663023, "SandP52WeekChange": 0.16885936, "lastDividendValue": 15.118, "lastDividendDate": 1697760000, "quoteType": "EQUITY", "currentPrice": 47.61, "targetHighPrice": 48.0, "targetLowPrice": 35.0, "targetMeanPrice": 46.5, "targetMedianPrice": 48.0, "recommendationMean": 2.6, "recommendationKey": "hold", "numberOfAnalystOpinions": 9, "totalCash": 239234000, "totalCashPerShare": 9.312, "ebitda": -102406000, "totalDebt": 145000, "quickRatio": 23.698, "currentRatio": 24.676, "debtToEquity": 0.056, "returnOnAssets": -0.20854001, "returnOnEquity": -0.29615998, "freeCashflow": -53317624, "operatingCashflow": -86276000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TRML", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1757721540, "regularMarketTime": 1757707200, "exchange": "NMS", "messageBoardId": "finmb_1843009393", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0210129, "regularMarketPrice": 47.61, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1620394200000, "postMarketChangePercent": -0.125819, "postMarketPrice": 47.5501, "postMarketChange": -0.0599022, "regularMarketChange": 0.0100021, "regularMarketDayRange": "47.59 - 47.695", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 655598, "fiftyTwoWeekLowChange": 36.05, "fiftyTwoWeekLowChangePercent": 3.118512, "fiftyTwoWeekRange": "11.56 - 47.7", "fiftyTwoWeekHighChange": -0.09000015, "fiftyTwoWeekHighChangePercent": -0.0018867956, "fiftyTwoWeekChangePercent": 136.63022, "dividendDate": 1697760000, "earningsTimestamp": 1754539200, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.44, "epsForward": -3.64, "epsCurrentYear": -3.805, "priceEpsCurrentYear": -12.512484, "fiftyDayAverageChange": 24.214401, "fiftyDayAverageChangePercent": 1.034998, "twoHundredDayAverageChange": 28.782625, "twoHundredDayAverageChangePercent": 1.5287646, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Tourmaline Bio, Inc.", "longName": "Tourmaline Bio, Inc.", "displayName": "Tourmaline Bio", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]